X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pramipexole (188) 188
humans (140) 140
index medicus (103) 103
parkinson's disease (99) 99
clinical neurology (95) 95
parkinson disease - drug therapy (85) 85
ropinirole (79) 79
male (73) 73
double-blind (71) 71
pharmacology & pharmacy (69) 69
female (68) 68
middle aged (60) 60
aged (57) 57
dopamine (56) 56
levodopa (53) 53
dopamine agonists - therapeutic use (47) 47
dopamine agonists - adverse effects (44) 44
restless legs syndrome (43) 43
neurosciences (42) 42
dopamine agonists (39) 39
rotigotine (38) 38
parkinsons-disease (36) 36
antiparkinson agents - therapeutic use (35) 35
adult (34) 34
efficacy (32) 32
antiparkinson agents - adverse effects (30) 30
drug therapy (30) 30
neurology (30) 30
dopamine agonist (29) 29
double-blind method (28) 28
parkinsons disease (28) 28
placebo-controlled trial (28) 28
treatment outcome (28) 28
psychiatry (27) 27
restless legs syndrome - drug therapy (27) 27
dopamine agonists - administration & dosage (26) 26
sleep (24) 24
tetrahydronaphthalenes - administration & dosage (24) 24
thiophenes - administration & dosage (24) 24
benzothiazoles - therapeutic use (23) 23
severity of illness index (23) 23
movement disorders (22) 22
tetrahydronaphthalenes - adverse effects (22) 22
tetrahydronaphthalenes - therapeutic use (22) 22
therapy (22) 22
thiophenes - adverse effects (22) 22
thiophenes - therapeutic use (22) 22
analysis (21) 21
administration, cutaneous (20) 20
bromocriptine (20) 20
care and treatment (20) 20
clinical trials (20) 20
management (20) 20
randomized controlled-trial (20) 20
animals (19) 19
cabergoline (19) 19
placebo (19) 19
augmentation (18) 18
dopamine receptors (18) 18
neurodegenerative diseases (18) 18
pergolide (18) 18
pramipexole, adverse reactions (18) 18
safety (18) 18
antiparkinsonian agents (16) 16
depression (16) 16
drug therapy, combination (16) 16
levodopa - adverse effects (16) 16
levodopa - therapeutic use (16) 16
motor fluctuations (16) 16
dosage and administration (15) 15
dose-response relationship, drug (15) 15
l-dopa (15) 15
aged, 80 and over (14) 14
agonists (14) 14
benzothiazoles - adverse effects (14) 14
complications and side effects (14) 14
medicine & public health (14) 14
multicenter (14) 14
parkinson’s disease (14) 14
transdermal medication (14) 14
drugs (13) 13
dyskinesia (13) 13
parkinson disease - complications (13) 13
parkinson disease - physiopathology (13) 13
research (13) 13
dopa (12) 12
indoles - therapeutic use (12) 12
open-label (12) 12
transdermal patch (12) 12
antiparkinson agents - administration & dosage (11) 11
controlled-trial (11) 11
phenols (11) 11
risk factors (11) 11
sleep medicine (11) 11
apomorphine (10) 10
benzothiazoles (10) 10
disorders (10) 10
entacapone (10) 10
episodes (10) 10
impulse control disorders (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Medicine, Journal of the Royal College of Physicians of London, ISSN 1470-2118, 06/2018, Volume 18, Issue 3, pp. 259 - 260
Dopamine agonists such as pramipexole are commonly used in the treatment of restless legs syndrome (RLS) as well as Parkinson's disease. Pramipexole's common... 
Skin | Pramipexole | Adverse Reaction | skin | MEDICINE, GENERAL & INTERNAL | adverse reaction | PARKINSONS-DISEASE | Restless legs syndrome | Ultraviolet radiation | Side effects | Sleep | Dopamine | Parkinsons disease | Family medical history | Lessons of the Month
Journal Article
Medicine, ISSN 1357-3039, 04/2011, Volume 39, Issue 4, pp. 239 - 241
The risk of an adverse drug reaction can vary markedly from one patient to the next, and the factors that determine an individual's susceptibility to an... 
ropinirole | myopathy | pramipexole | nephrogenic systemic fibrosis | skin disorders | osteonecrosis | adverse drug reaction | statins | punding | abacavir | bisphosphonates | sleep attack | gadolinium
Journal Article
CNS Drugs, ISSN 1172-7047, 2010, Volume 24, Issue 11, pp. 941 - 968
Journal Article
REVISTA MEDICA DE CHILE, ISSN 0034-9887, 12/2017, Volume 145, Issue 12, pp. 1624 - 1625
Journal Article
Movement Disorders, ISSN 0885-3185, 11/2004, Volume 19, Issue 11, pp. 1370 - 1374
Journal Article
Journal Article
Expert Opinion on Drug Metabolism & Toxicology, ISSN 1742-5255, 07/2013, Volume 9, Issue 7, pp. 859 - 874
Introduction: The development of pharmacogenetic-based clinical practice guidelines for the use of anti-Parkinson's disease drugs requires, as a pre-requisite,... 
adverse drug reactions | Parkinson's disease | pharmacogenomics | biomarkers | pharmacogenetics | Biomarkers | Pharmacogenetics | Adverse drug reactions | Pharmacogenomics | HUMAN PLASMA | INTRAETHNIC VARIABILITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | AMANTADINE ACETYLATION | SINGLE-DOSE PHARMACOKINETICS | CLINICAL PHARMACOKINETICS | DECARBOXYLASE INHIBITOR | LEVODOPA THERAPY | CATECHOL-O-METHYLTRANSFERASE | METABOLISM | PHARMACOLOGY & PHARMACY | TOXICOLOGY | HEALTHY-VOLUNTEERS | Humans | Receptors, Dopamine D3 - metabolism | Aryl Hydrocarbon Hydroxylases - genetics | Parkinson Disease - drug therapy | Receptors, Dopamine D2 - metabolism | Indans - therapeutic use | Bromocriptine - therapeutic use | Pramipexole | Cytochrome P-450 CYP1A2 Inhibitors | Lisuride - therapeutic use | Receptors, Dopamine D3 - genetics | Cytochrome P-450 CYP3A - genetics | Catechols - therapeutic use | Selegiline - therapeutic use | Benztropine - therapeutic use | Reproducibility of Results | Levodopa - therapeutic use | Genetic Markers | Parkinson Disease - genetics | Cytochrome P-450 CYP1A2 - metabolism | Pergolide - therapeutic use | Receptors, Dopamine D2 - genetics | Aryl Hydrocarbon Hydroxylases - metabolism | Ergolines - therapeutic use | Cytochrome P-450 CYP2C19 | Cytochrome P-450 CYP3A - metabolism | Indoles - therapeutic use | Benzothiazoles - therapeutic use | Cabergoline | Cytochrome P-450 CYP2B6 | Nitriles - therapeutic use | Index Medicus
Journal Article
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, ISSN 0720-4299, 08/2011, Volume 79, Issue 8, pp. 470 - 474
Problems with impulse control and pathological gambling are known as possible side effects of dopaminergic therapy in patients with Parkinson's disease. We... 
ropinirole | prolactinoma | PSYCHIATRY | DISORDERS | cabergoline | ADVERSE DRUG-REACTIONS | CLINICAL NEUROLOGY | impulse control disorder | COMPULSIVE BEHAVIORS | PROBABILITY | RESTLESS LEGS SYNDROME | PRAMIPEXOLE | REINFORCEMENT | CASE SERIES | PARKINSONS-DISEASE | SUBSTANCE
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.